Shares of Vertex Pharmaceuticals Inc.
slid 1.42% to $214.85 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average
rising 0.06% to 34,133.03 and the S&P 500 Index
falling 0.67% to 4,164.66. This was the stock's second consecutive day of losses. Vertex Pharmaceuticals Inc. closed $91.23 short of its 52-week high ($306.08), which the company reached on July 7th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson
rose 1.55% to $167.77, Merck & Co. Inc.
rose 0.01% to $75.99, and AbbVie Inc.
fell 0.68% to $113.90. Trading volume (1.8 M) remained 30,821 below its 50-day average volume of 1.8 M.